KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • Idexx Laboratories' Change in Inventory fell 11013.32% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 7496.78%. This contributed to the annual value of $28.0 million for FY2024, which is 226.87% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Change in Inventory is -$1.9 million, which was down 11013.32% from $6.2 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Change in Inventory peaked at $50.3 million during Q3 2022, and registered a low of -$7.3 million during Q3 2023.
  • Over the past 5 years, Idexx Laboratories' median Change in Inventory value was $7.9 million (recorded in 2021), while the average stood at $12.3 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 73605.57% in 2021, then crashed by 18967.66% in 2025.
  • Quarter analysis of 5 years shows Idexx Laboratories' Change in Inventory stood at $6.0 million in 2021, then surged by 266.79% to $22.1 million in 2022, then tumbled by 113.55% to -$3.0 million in 2023, then soared by 208.31% to $3.2 million in 2024, then plummeted by 157.9% to -$1.9 million in 2025.
  • Its last three reported values are -$1.9 million in Q3 2025, $6.2 million for Q2 2025, and -$2.2 million during Q1 2025.